Philip Morris International
Philip Morris International's revenue rose 7.3% to $40.6 billion in fiscal 2025. Its operating margin was 36.6%, up from 35.4% a year earlier. Free cash flow was $10.7 billion, down 1.0%. It paid out $8.6 billion in dividends and buybacks, 81% of free cash flow. The diluted share count rose 0.1%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
What Philip Morris International does
Philip Morris International sells cigarettes and nicotine products that don't burn tobacco. Its cigarettes, led by Marlboro, along with Parliament, Chesterfield, L&M and Philip Morris, are sold in about 170 markets. Its smoke-free products include IQOS, a device that heats tobacco instead of burning it, ZYN nicotine pouches, General snus and VEEV e-cigarettes, sold in 106 markets. In the US its products include ZYN, and it holds the full US rights to IQOS. It sells to retailers directly and through distributors and wholesalers, and also online and in its own stores.
Net revenues were $40.6 billion in 2025, of which $16.9 billion came from smoke-free products. Marlboro made up about 43% of the cigarettes it shipped. Japan is its largest market by revenue. The company says its goal is to stop selling cigarettes entirely in favor of smoke-free products. It competes with Altria, British American Tobacco, Japan Tobacco, Imperial Brands, newer companies and state-owned tobacco firms in some countries.
PMI bought Swedish Match, the maker of ZYN, in 2022. Starting in 2026 it reports three segments: International Smoke-Free, International Combustibles and the US. It employed about 84,900 people at the end of 2025.
Its biggest risks, as it describes them
- Failing to grow its smoke-free products, or regulators banning or tightly restricting them.
- Cigarette sales keep falling in many of its markets.
- Government rules and taxes aimed at cutting tobacco and nicotine use.
- Lawsuits over tobacco and nicotine products that could cut its profits.
- Smuggled, counterfeit and other illegal products that take away sales.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 5.5% a year and net income 5.6% a year, with the share count about the same.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Philip Morris International yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
What Philip Morris International says to expect
- Full year 2026: reported diluted EPS
Reported diluted EPS is forecast to be in a range of $7.11 to $7.26, at prevailing exchange rates.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Philip Morris International's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Philip Morris International's fiscal 2025 free cash flow of $10.7B, net cash of −$44.0B at December 31, 2025 and 1,558 million diluted shares, from its filings. The scenarios are fitted to Philip Morris International: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 8.6% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 7% for a stable business (Tobacco); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $201.87
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Philip Morris International's earnings per share of $6.85 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 29.5×, the middle of Philip Morris International's own P/E today, its peers' median and its sector's median (Philip Morris International's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 8%, 7% and 6%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $201.87
- Value at this multiple, against the last close
- —
- Philip Morris International's P/E at the last close
- 29.5×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| UniversalUVV | $38.96 | $0.76 | 51.3× |
| US FoodsUSFD | $101.36 | $3.25 | 31.2× |
| Philip Morris InternationalPM | $201.87 | $6.85 | 29.5× |
| AltriaMO | $73.62 | $4.75 | 15.5× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 4.5 | 3.2 | 3.1 | 4.2 | 4.9 |
| Debt incl. finance leases | 27.8 | 43.1 | 47.9 | 45.7 | 48.8 |
| Net debt (negative means net cash) | 23.3 | 39.9 | 44.8 | 41.5 | 44.0 |
| Net debt to EBITDA | 1.7x | 3.0x | 3.5x | 2.7x | 2.6x |
| Debt to equity | — | — | — | — | — |
| Interest coverage | 17.6x | 15.9x | 7.6x | 7.6x | 9.4x |
| Current ratio | 0.9x | 0.7x | 0.8x | 0.9x | 1.0x |
| Quick ratio | 0.5x | 0.4x | 0.3x | 0.5x | 0.5x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Philip Morris International shares on the open market, and 6 insiders sold $28.8 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 2026 | Stacey KennedyCEO Pmi U.s. | Sold | 14,350 | $183.13 | $2.6 million | Form 4 |
| Feb 20, 2026 | Reginaldo DobrowolskiGroup Controller | Sold | 6,000 | $183.48 | $1.1 million | Form 4 |
| Feb 19, 2026 | Jacek OlczakGroup CEO PMI, Director | Sold | 80,000 | $182.18 | $14.6 million | Form 4 |
| Feb 19, 2026 | Emmanuel BabeauGroup Chief Financial Officer | Sold | 33,800 | $181.61 | $6.1 million | Form 4 |
| Feb 19, 2026 | Wilde Frederic DeCEO PMI International | Sold | 20,000 | $182.58 | $3.7 million | Form 4 |
| Feb 19, 2026 | Yann GuerinGroup Chief Legal Officer | Sold | 4,000 | $181.69 | $726,760 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 5 of 9 | 7 of 9 | 7 of 9 |
| Accruals ratio | −2.2% | −8.1% | −1.4% |
Compare
Put Philip Morris International side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Philip Morris International | FY25 | 7.3% | 36.6% | 26.2% | 35.4% | 2.6x | 7 | |
| British American Tobacco | FY25 | −1.0% | 39.0% | 22.6% | 9.8% | — | 6 | Compare |
| Altria | FY25 | −3.1% | 42.5% | 39.0% | 39.2% | 2.1x | 7 | Compare |
| Universal | FY26 | −1.3% | 5.8% | 2.8% | 4.0% | 3.8x | 5 | Compare |
| US Foods | FY25 | 4.1% | 3.0% | 2.4% | 9.6% | 3.1x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 26.7 | 28.7 | 29.6 | 29.8 | 28.7 | 31.4 | 31.8 | 35.2 | 37.9 | 40.6 |
| Revenue growth | −63.9% | 7.7% | 3.0% | 0.6% | −3.7% | 9.4% | 1.1% | 10.7% | 7.7% | 7.3% |
| Gross profit | 17.3 | 18.3 | 18.9 | 19.3 | 19.1 | 21.4 | 20.4 | 22.3 | 24.5 | 27.3 |
| Research and development | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 |
| Operating income | 10.9 | 11.6 | 11.4 | 10.5 | 11.7 | 13.0 | 12.2 | 11.6 | 13.4 | 14.9 |
| Net income | 7.0 | 6.0 | 7.9 | 7.2 | 8.1 | 9.1 | 9.0 | 7.8 | 7.1 | 11.3 |
| Diluted EPS (US$) | 4.48 | 3.88 | 5.08 | 4.61 | 5.16 | 5.83 | 5.81 | 5.02 | 4.52 | 7.26 |
| Diluted shares (millions) | 1,551 | 1,553 | 1,555 | 1,556 | 1,558 | 1,559 | 1,552 | 1,553 | 1,556 | 1,558 |
| Cash flow | ||||||||||
| Cash from operations | 8.1 | 8.9 | 9.5 | 10.1 | 9.8 | 12.0 | 10.8 | 9.2 | 12.2 | 12.2 |
| Capital expenditure | 1.2 | 1.5 | 1.4 | 0.9 | 0.6 | 0.7 | 1.1 | 1.3 | 1.4 | 1.6 |
| Free cash flow | 6.9 | 7.4 | 8.0 | 9.2 | 9.2 | 11.2 | 9.7 | 7.9 | 10.8 | 10.7 |
| Dividends paid | 6.4 | 6.5 | 6.9 | 7.2 | 7.4 | 7.6 | 7.8 | 8.0 | 8.2 | 8.6 |
| Share buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.2 | 0.0 | 0.0 | 0.0 |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 14.0 | 0.0 | 0.0 | 0.0 |
| Stock-based compensation | — | — | — | — | — | — | — | — | — | — |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 4.2 | 8.4 | 6.6 | 6.9 | 7.3 | 4.5 | 3.2 | 3.1 | 4.2 | 4.9 |
| Debt incl. finance leases | 29.1 | 34.3 | 31.8 | 31.0 | 31.5 | 27.8 | 43.1 | 47.9 | 45.7 | 48.8 |
| Total assets | 36.9 | 43.0 | 39.8 | 42.9 | 44.8 | 41.3 | 61.7 | 65.3 | 61.8 | 69.2 |
| Total liabilities | 47.8 | 53.2 | 50.5 | 52.5 | 55.4 | 49.5 | 68.0 | 74.8 | 71.7 | 77.2 |
| Shareholders' equity | −12.7 | −12.1 | −12.5 | −11.6 | −12.6 | −10.1 | −9.0 | −11.2 | −11.8 | −10.0 |
| Margins and ratios | ||||||||||
| Gross margin | 64.8% | 63.7% | 63.7% | 64.7% | 66.7% | 68.1% | 64.1% | 63.4% | 64.8% | 67.1% |
| Operating margin | 40.9% | 40.3% | 38.4% | 35.3% | 40.7% | 41.3% | 38.6% | 32.9% | 35.4% | 36.6% |
| Net margin | 26.1% | 21.0% | 26.7% | 24.1% | 28.1% | 29.0% | 28.5% | 22.2% | 18.6% | 27.9% |
| Free cash flow margin | 25.9% | 25.6% | 27.1% | 31.0% | 32.1% | 35.7% | 30.6% | 22.4% | 28.4% | 26.2% |
| Return on capital | 57.1% | 46.4% | 58.3% | 55.7% | 64.8% | 70.6% | 40.6% | 26.0% | 30.1% | 35.4% |
| Return on equity | — | — | — | — | — | — | — | — | — | — |
| Return on assets | 19.7% | 15.1% | 19.1% | 17.4% | 18.4% | 21.2% | 17.6% | 12.3% | 11.1% | 17.3% |
| Net debt to EBITDA | 2.1x | 2.1x | 2.0x | 2.1x | 1.9x | 1.7x | 3.0x | 3.5x | 2.7x | 2.6x |